SK

Sunil Kumar Ajar

Active Director Director DIN 07812055
DIN 07812055 First appointment Nov 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2017
Shareholding value •••• Premium profile

About Sunil Kumar Ajar

Data last updated:

Sunil Kumar Ajar is a Director at Augment Pharmaceutical Private Limited (since 2017). The company operates in Pharma. Augment Pharmaceutical Private Limited reported revenue of ₹13.4 Lakh (FY 2024).

DIN 07812055
Primary Designation Director
Industry Pharma
First Appointment 06 Nov 2017
Oldest Company Age 9 yrs
Largest company Augment Pharmaceutical Private Limited · ₹13.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Nov 20172017₹13.4 Lakh (FY 2024)Active

Board colleagues of Sunil Kumar Ajar

NameDINCompanyDesignation
Manju Shri07812038Augment Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Augment Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sunil Kumar Ajar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Kumar Ajar

Sunil Kumar Ajar currently holds 1 directorship: Augment Pharmaceutical Private Limited (Director, since 06 Nov 2017, revenue ₹13.4 Lakh (FY 2024)).

Sunil Kumar Ajar was first appointed on 06 Nov 2017 as Director at Augment Pharmaceutical Private Limited.

The current boards of Sunil Kumar Ajar's companies include Manju Shri (Augment Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available